Cite
HARVARD Citation
Hyland, E. et al. (n.d.). Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira® in healthy subjects. British journal of clinical pharmacology. pp. 983-993. [Online].